Skip to main content
21 January 2021
Last updated:
Thursday 21 January 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us

Research Directory

  • Mitochondrial quality control as potential therapy

    Sunday 18 March 2018
    Interviewee/Contributor
    Paul Thompson
    Organisation
    Mission Therapeutics
    Drug discovery
    Strategy
    • Read more about Mitochondrial quality control as potential therapy

Organisations

  • Bellevue Asset Management
  • Aravis Venture
  • BioLizard NV
  • Harvard Stem Cell Institute
  • Zelluna Immunotherapy AS
  • Takeda Ventures
  • Karolinska Institutet
  • Eli Lilly and Company
  • MRC Technology
  • Innovative Medicines Initiative (IMI)

Interviewees and Contributers

  • Willem de Laat
  • Walter Schmidt
  • Jennifer Hannesschlager
  • Philip Wright
  • Oliver Rausch
  • Bjorn Herpers
  • Emanuel Björne
  • Reisa Sperling
  • Geert Walther Nygaard
  • Rob Meijer

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

T-knife appoints Thomas Soloway as chief executive
Thursday January 21 2021
Domainex makes two executive appointments
Thursday January 21 2021
Richard Francis named CEO of Purespring
Tuesday January 19 2021
Klaas Zuideveld becomes CEO of Versameb
Saturday January 16 2021
MorphoSys appoints new CFO
Thursday January 7 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.